The results revealed that compared with normal tissues, the expression level of GNG7 was significantly lower in several malignancies, including STAD, colon adenocarcinoma, rectum adenocarcinoma, and others (P < 0.01; Figure 7A). This evidence concerns the gene GNG7 and rectum adenocarcinoma.